EXEL
Price
$51.33
Change
-$0.02 (-0.04%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
12.9B
42 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$38.20
Change
-$0.23 (-0.60%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.74B
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EXEL vs VERA

EXEL vs VERA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EXEL vs. VERA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXEL is a StrongBuy and VERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (EXEL: $51.32 vs. VERA: $38.20)
Brand notoriety: EXEL: Notable vs. VERA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXEL: 95% vs. VERA: 175%
Market capitalization -- EXEL: $12.9B vs. VERA: $2.74B
EXEL [@Biotechnology] is valued at $12.9B. VERA’s [@Biotechnology] market capitalization is $2.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXEL’s FA Score shows that 2 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • EXEL’s FA Score: 2 green, 3 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, EXEL is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXEL’s TA Score shows that 2 TA indicator(s) are bullish while VERA’s TA Score has 4 bullish TA indicator(s).

  • EXEL’s TA Score: 2 bullish, 5 bearish.
  • VERA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, VERA is a better buy in the short-term than EXEL.

Price Growth

EXEL (@Biotechnology) experienced а -1.50% price change this week, while VERA (@Biotechnology) price change was +13.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.83%. For the same industry, the average monthly price growth was +1.96%, and the average quarterly price growth was +1945.11%.

Reported Earning Dates

EXEL is expected to report earnings on Aug 05, 2026.

VERA is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXEL($12.9B) has a higher market cap than VERA($2.74B). EXEL YTD gains are higher at: 17.089 vs. VERA (-24.566). EXEL has higher annual earnings (EBITDA): 986M vs. VERA (-360.87M). EXEL has more cash in the bank: 777M vs. VERA (597M). VERA has less debt than EXEL: VERA (76.9M) vs EXEL (170M). EXEL has higher revenues than VERA: EXEL (2.38B) vs VERA (0).
EXELVERAEXEL / VERA
Capitalization12.9B2.74B470%
EBITDA986M-360.87M-273%
Gain YTD17.089-24.566-70%
P/E Ratio17.00N/A-
Revenue2.38B0-
Total Cash777M597M130%
Total Debt170M76.9M221%
FUNDAMENTALS RATINGS
EXEL: Fundamental Ratings
EXEL
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
23
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EXELVERA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
65%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
EXEL
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLK14.430.31
+2.20%
PT Telekomunikasi Indonesia
BOXL3.590.01
+0.22%
Boxlight Corporation
ABM43.910.05
+0.11%
ABM Industries
FVN10.93N/A
N/A
Future Vision II Acquisition Corp.
MCTA29.35N/A
N/A
Charming Medical Ltd.